Abstract
Statin-fibrate combinations are commonly used to treat hyperlipidemia. These drugs have been previously reported to cause rhabdomyolysis with acute renal failure. Whether different statin-fibrate combinations have different risks for rhabdomyolysis is not known. We report a patient who developed rhabdomyolysis with acute renal failure pomptly after switching from the combination of pravastatin and fenofibrate to simvastatin and gemfibrozil.
| Original language | English |
|---|---|
| Pages (from-to) | 127-128 |
| Number of pages | 2 |
| Journal | Cardiology |
| Volume | 94 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2000 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine
Cite this
Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations. / Oldemeyer, J. Bradley; Lund, Richard J.; Koch, Matt; Meares, A. John; Dunlay, Robert W.
In: Cardiology, Vol. 94, No. 2, 2000, p. 127-128.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations
AU - Oldemeyer, J. Bradley
AU - Lund, Richard J.
AU - Koch, Matt
AU - Meares, A. John
AU - Dunlay, Robert W.
PY - 2000
Y1 - 2000
N2 - Statin-fibrate combinations are commonly used to treat hyperlipidemia. These drugs have been previously reported to cause rhabdomyolysis with acute renal failure. Whether different statin-fibrate combinations have different risks for rhabdomyolysis is not known. We report a patient who developed rhabdomyolysis with acute renal failure pomptly after switching from the combination of pravastatin and fenofibrate to simvastatin and gemfibrozil.
AB - Statin-fibrate combinations are commonly used to treat hyperlipidemia. These drugs have been previously reported to cause rhabdomyolysis with acute renal failure. Whether different statin-fibrate combinations have different risks for rhabdomyolysis is not known. We report a patient who developed rhabdomyolysis with acute renal failure pomptly after switching from the combination of pravastatin and fenofibrate to simvastatin and gemfibrozil.
UR - http://www.scopus.com/inward/record.url?scp=0034487393&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034487393&partnerID=8YFLogxK
U2 - 10.1159/000047304
DO - 10.1159/000047304
M3 - Article
VL - 94
SP - 127
EP - 128
JO - Cardiology
JF - Cardiology
SN - 0008-6312
IS - 2
ER -